Cervical TsDCS on Stroke Patients
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorIRCCS San Raffaele Roma
About this trial
The present project aims to evaluate the facilitatory modulation of motor responses of the limb upper limb by tsDCS in patients with arm/hand hyposthenia after cerebral ischemia to verify the possible therapeutic benefits that this type of stimulation can induce in terms of of strength, dexterity and effectiveness in acts of daily living.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
age over 18 years;
first ischemic/hemorrhagic stroke (within 30 days of onset);
mild-to-moderate stroke (NIHSS scale score<16).
residual function of the upper limb, assessed by the following scales: - MRC of the distal muscles of the upper limb: score between 2 and 4; - NHISS (items 5A and 5B): score between 1 and 3;
Disqualifiers
severe spasticity (Ashworth Scale score > 2);
severe aphasia;
severe neglect;
history of disabling neurological disease;
Trial design
Design model
Crossover
Treatments tested in this trial
tDCS
Other interventionTranscranial direct current stimulation
Treatment groups
40 Participants
are divided into 2 treatment groupsGroup A: StrokeExperimental treatment 1 intervention
Group B: HealthyExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
improvement of paretic hand performance
The primary outcome measure is the improvement in hand strength and dexterity in individuals with upper limb motor impairment following cerebral ischemia, after the application of tsDCS at the cervical spinal level during Reaching
Time frame
through study completion, an average of 1 year2
improvement of paretic hand performance
The primary outcome measure is the improvement in hand strength and dexterity in individuals with upper limb motor impairment following cerebral ischemia, after the application of tsDCS at the cervical spinal level during Grasping
Time frame
through study completion, an average of 1 year3
improvement of paretic hand performance
The primary outcome measure is the improvement in hand strength and dexterity in individuals with upper limb motor impairment following cerebral ischemia, after the application of tsDCS at the cervical spinal level during Lifting test
Time frame
through study completion, an average of 1 year4
improvement of paretic hand performance
The primary outcome measure is the improvement in hand strength and dexterity in individuals with upper limb motor impairment following cerebral ischemia, after the application of tsDCS at the cervical spinal level duringthe Nine Hole Peg test
Time frame
through study completion, an average of 1 yearSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: